Salapuddin, Mudzremar K.
HRN: 27-03-57 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
ACICLOVIR 400MG (TAB)
04/26/2025
05/17/2025
PO PER NGT
110mg
TID
CNSI; T/C Japanese Encephalitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamCentral Nervous SystemProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes